Tech Company Financing Transactions
Neuspera Funding Round
On 7/15/2024, Neuspera raised $23 million in Series D funding from Treo Ventures, Vertex Ventures HC and Action Potential Venture Capital.
Transaction Overview
Company Name
Announced On
7/15/2024
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series D
Investors
Treo Ventures (Lead Investor) (Mudit Jain)
Vertex Ventures HC (Lead Investor) (Lori Hu)
Proceeds Purpose
The company intends to use the funds to further enhance its growth through expected U.S. Food and Drug Association (FDA) premarket approval (PMA) of its system.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
51 Daggett Dr.
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
We are on the forefront of bioelectric medicine to treat many chronic and debilitating diseases. Our ultra miniaturized medicines are safer, smaller and more affordable. We will drive greater accessibility and adoption by empowering users to take control of their treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Milton Morris
Chief Technical Officer
Alexander Yeh
VP - Operations
Steve Schellenberg
VP - R & D
Timothy Ciciarelli
VP - Regulatory Affairs
Andrina Hougham
Browse more venture capital transactions:
Prev: 7/15/2024: Tapi venture capital transaction
Next: 7/15/2024: Bima Labs venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs